GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (FRA:KB7) » Definitions » ROE % Adjusted to Book Value

Solventum (FRA:KB7) ROE % Adjusted to Book Value : 1.09% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solventum ROE % Adjusted to Book Value?

Solventum's ROE % for the quarter that ended in Dec. 2024 was 4.15%. Solventum's PB Ratio for the quarter that ended in Dec. 2024 was 3.82. Solventum's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 1.09%.


Solventum ROE % Adjusted to Book Value Historical Data

The historical data trend for Solventum's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum ROE % Adjusted to Book Value Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
- - - - 1.77

Solventum Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 3.38 4.30 1.09

Competitive Comparison of Solventum's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Solventum's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solventum's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Solventum's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Solventum's ROE % Adjusted to Book Value falls into.


;
;

Solventum ROE % Adjusted to Book Value Calculation

Solventum's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.77% / 3.82
=1.77%

Solventum's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.15% / 3.82
=1.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solventum ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Solventum's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Solventum Business Description

Traded in Other Exchanges
Address
2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.

Solventum Headlines

No Headlines